Discovery Life Sciences Acquires ReachBio Research Labs

"We share Discovery's passion for science and believe that combining our expertise in cell-based assays and drug screening with Discovery's broad multi-omics capabilities will enable us to provide a broader and more strategic range of services to clients in the pharmaceutical industry."

- Emer Clarke, CSO ReachBio

THE CELL BIOLOGY EXPERTS™️

ReachBio Research Labs provides primary cell biology based contract research services and products to the drug development and life science research communities.

Discover

Services

Our use of primary cell systems allows us to provide our clients with more predictable and clinically-relevant assays.

Products

Extensive knowledge allows us to provide high quality primary cells from bone marrow and peripheral blood.

News

The latest news, updates, and information from our lab in Seattle, WA.

PREDICTIVE HEMATOTOXICITY

We specialize in testing new compounds with their potential to cause clinical neutropenia, thrombocytopenia, anemia, and other program challenges.

WATCH + LEARN

Our latest video highlights the colony forming cell assay. CFC assays can predict compound induced toxicities including neutropenia, thrombocytopenia, and severe anemia. Drug candidates can be tested alone or in combination with other therapeutics.

IMMUNE PROFILING & FLOW CYTOMETRY SERVICES

We have multi-color flow cytometry and cell sorting capabilities. In addition to looking at T cells, B cells, and NK cells, we can examine helper T cell subsets by both surface staining and intracellular staining.

ANTIBODIES, ANTIVIRALS, KINASE INHIBITORS AND MORE!

From small molecules to complex biologics. We test a variety of compound classes for potential hematotoxicity in our highly predictive in vitro assay systems.